Opus Genetics, Inc. (IRD)
3.64
+0.25
(+7.37%)
USD |
NASDAQ |
Feb 13, 16:00
3.635
0.00 (0.00%)
After-Hours: 20:00
Opus Genetics Total Assets (Quarterly) : 36.12M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Moderna, Inc. | 12.34B |
| ACADIA Pharmaceuticals, Inc. | 1.331B |
| Alnylam Pharmaceuticals, Inc. | 5.026B |
| Savara, Inc. | 140.92M |
| BioMarin Pharmaceutical, Inc. | 7.615B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 30.16M |
| Shareholders Equity (Quarterly) | 5.967M |
| Debt to Equity Ratio | 0.179 |
| Current Ratio | 1.235 |
| Net Debt Paydown Yield | -0.20% |